| 1 |
venous thromboembolism
(8973 times)
|
Vascular Diseases
(2225 times)
|
DVT (1428 times)
PE (1327 times)
CI (919 times)
|
0 [Current Recommendations for the Prevention and Treatment of Venous Thromboembolism in Cancer Patients].
|
| 2 |
venous thromboembolic events
(354 times)
|
Vascular Diseases
(72 times)
|
PE (54 times)
DVT (49 times)
LMWH (35 times)
|
1995 [A nonpharmacological therapeutic strategy: inferior vena cava filters (IVC) in the treatment of venous thromboembolic disease (VTE). The PTE Working Group of SEPAR. Sociedad Espanola de Neumologia y Cirurgia Toracica].
|
| 3 |
vicarious trial and error
(23 times)
|
Behavioral Sciences
(10 times)
|
SA (2 times)
SAB (2 times)
8-OH-DPAT (1 time)
|
1956 On the origin and early use of the term vicarious trial and error (VTE).
|
| 4 |
vascular tissue engineering
(6 times)
|
Biomedical Engineering
(2 times)
|
ECM (1 time)
ECs (1 time)
FESEM (1 time)
|
2007 Macromolecular biomaterials for scaffold-based vascular tissue engineering.
|
| 5 |
vitamin E
(6 times)
|
Botany
(4 times)
|
QTL (2 times)
DG (1 time)
DGK (1 time)
|
2006 Tocopherols play a crucial role in low-temperature adaptation and Phloem loading in Arabidopsis.
|
| 6 |
venous thromboembolic complications
(5 times)
|
Neurology
(1 time)
|
DVT (2 times)
PE (2 times)
CVLs (1 time)
|
1994 Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE.
|
| 7 |
venous thromboembolism prophylaxis
(5 times)
|
Clinical Medicine
(1 time)
|
ACOVE (1 time)
CI (1 time)
DVT (1 time)
|
2011 Perioperative deep vein thrombosis prevention: what works, what does not work and does it improve outcome?
|
| 8 |
vascular thromboembolism
(4 times)
|
Thrombosis
(1 time)
|
APC (2 times)
CI (2 times)
CMV (1 time)
|
2012 Gemcitabine versus gemcitabine plus dalteparin thromboprophylaxis in pancreatic cancer.
|
| 9 |
venous TE
(4 times)
|
Hematology
(2 times)
|
ATE (3 times)
TE (3 times)
APLA (1 time)
|
2004 Anticoagulant therapy for the thrombotic complications of the antiphospholipid antibody syndrome.
|
| 10 |
vacuum thermal evaporation
(3 times)
|
Nanotechnology
(2 times)
|
AFM (1 time)
OVPD (1 time)
|
2007 Localized current injection and submicron organic light-emitting device on a pyramidal atomic force microscopy tip.
|
| 11 |
ventricular tachyarrhythmic events
(3 times)
|
Cardiology
(2 times)
|
SCD (2 times)
APD (1 time)
ECG (1 time)
|
2010 Improved survival among ventricular assist device recipients with a concomitant implantable cardioverter-defibrillator.
|
| 12 |
Volume-based Template Estimation
(3 times)
|
Diagnostic Imaging
(2 times)
|
ABA (1 time)
DTI (1 time)
FA (1 time)
|
2014 Evaluation of group-specific, whole-brain atlas generation using Volume-based Template Estimation (VTE): application to normal and Alzheimer's populations.
|
| 13 |
vacuum-thermic extraction
(2 times)
|
Chemistry Techniques, Analytical
(1 time)
|
---
|
1996 Vacuum-thermic extraction (VTE) of toxic and essential elements from rocks with subsequent AAS determination-II.
|
| 14 |
VEGF trap-eye
(2 times)
|
Ophthalmology
(1 time)
|
CRT (1 time)
CRVO (1 time)
IgG (1 time)
|
2013 VEGF Trap-Eye for macular oedema secondary to central retinal vein occlusion: 6-month results of the phase III GALILEO study.
|
| 15 |
venographic or symptomatic
(2 times)
|
Thrombosis
(2 times)
|
CI (1 time)
DVT (1 time)
ITT (1 time)
|
2007 Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE-MODEL randomized trial.
|
| 16 |
venous thrombosis and embolism
(2 times)
|
Gynecology
(1 time)
|
MI (1 time)
OC (1 time)
|
1999 Cardiovascular risks: perception versus reality.
|
| 17 |
verbal transformation effect
(2 times)
|
Biology
(1 time)
|
LPC (1 time)
RN (1 time)
RP (1 time)
|
2012 Perceptuo-motor interactions in the perceptual organization of speech: evidence from the verbal transformation effect.
|
| 18 |
vicarious trial-and-error behavior
(2 times)
|
Neurology
(1 time)
|
AMY (1 time)
LC-NA (1 time)
mPFC (1 time)
|
2014 Noradrenergic modulation of vicarious trial-and-error behavior during a spatial decision-making task in rats.
|
| 19 |
viral translational enhancer
(2 times)
|
Virology
(2 times)
|
GUS (1 time)
Luc (1 time)
PVS (1 time)
|
1994 Analysis of a translational enhancer upstream from the coat protein open reading frame of potato virus S.
|
| 20 |
VTE group
(2 times)
|
Cardiology
(1 time)
|
APTE (2 times)
IM (1 time)
|
2006 [Study of the echocardiographic diagnosis of acute pulmonary thromboembolism and risk factors for venous thromboembolism].
|
| 21 |
termed 'vicarious trial and error
(1 time)
|
Neurology
(1 time)
|
---
|
2016 Vicarious trial and error.
|
| 22 |
V-type ATPase subunit E
(1 time)
|
Chemistry
(1 time)
|
IAP (1 time)
RNAi (1 time)
|
2018 A Systematic Study of RNAi Effects and dsRNA Stability in Tribolium castaneum and Acyrthosiphon pisum, Following Injection and Ingestion of Analogous dsRNAs.
|
| 23 |
values of transepithelial potential differences
(1 time)
|
Physiology
(1 time)
|
---
|
1983 Reinvestigation of the transepithelial P.D. in the proximal tubule of Necturus kidney.
|
| 24 |
vancomycin-tolerant enterococci
(1 time)
|
Anti-Bacterial Agents
(1 time)
|
CDI (1 time)
|
2016 Efficacy of vancomycin extended-dosing regimens for treatment of simulated Clostridium difficile infection within an in vitro human gut model.
|
| 25 |
vapor-transport equilibration
(1 time)
|
Chemistry
(1 time)
|
---
|
2012 Influence of postgrowth Li-poor vapor-transport equilibration on the surface Li2O content of a congruent LiNbO3 crystal.
|
| 26 |
variable echo time
(1 time)
|
Diagnostic Imaging
(1 time)
|
CE-MRA (1 time)
Gd (1 time)
SI (1 time)
|
2008 Variable echo time imaging: signal characteristics of 1-M gadobutrol contrast agent at 1.5 and 3T.
|
| 27 |
Variable TE
(1 time)
|
Diagnostic Imaging
(1 time)
|
PSF (1 time)
TEs (1 time)
|
2002 Reduction of flow-related signal loss in flow-compensated 3D TOF MR angiography, using variable echo time (3D TOF-VTE).
|
| 28 |
variants when the event of interest
(1 time)
|
Environmental Health
(1 time)
|
CoxPH (1 time)
SNPs (1 time)
|
2017 Identification of Genetic Interaction with Risk Factors Using a Time-To-Event Model.
|
| 29 |
VDphys/expired tidal volume
(1 time)
|
Anesthesiology
(1 time)
|
PC-IRV (1 time)
PCV (1 time)
RLRP (1 time)
|
2018 Effect of pressure-controlled inverse ratio ventilation on dead space during robot-assisted laparoscopic radical prostatectomy: A randomised crossover study of three different ventilator modes.
|
| 30 |
vein thrombosis or pulmonary embolism
(1 time)
|
Orthopedics
(1 time)
|
NTDB RDS (1 time)
OR (1 time)
|
2018 Thromboembolic Events After Traumatic Vertebral Fractures: An Analysis of 190,192 Patients.
|
| 31 |
vena cava thrombosis
(1 time)
|
Pediatrics
(1 time)
|
PMBCL (1 time)
|
2015 [Superior vena cava thrombosis in patients with mediastinal large B-cell lymphoma: two pediatric cases].
|
| 32 |
veno-thrombolytic events
(1 time)
|
Nursing
(1 time)
|
VTEs (1 time)
|
2012 Educating nurses about veno-thrombolytic events (VTE).
|
| 33 |
venosen Thromboembolie
(1 time)
|
Vascular Diseases
(1 time)
|
---
|
2016 Prophylaxe der venosen Thromboembolie (VTE).
|
| 34 |
venous embolic or thrombotic
(1 time)
|
Neoplasms
(1 time)
|
CI (1 time)
EU (1 time)
HiDEX (1 time)
|
2015 The European medicines agency review of pomalidomide in combination with low-dose dexamethasone for the treatment of adult patients with multiple myeloma: summary of the scientific assessment of the committee for medicinal products for human use.
|
| 35 |
Venous lesions, including obstruction and thromboembolism
(1 time)
|
Cardiology
(1 time)
|
DD (1 time)
TM (1 time)
vWF (1 time)
|
2010 Clinical and laboratory risk factors of thrombotic complications after pacemaker implantation: a prospective study.
|
| 36 |
venous thromboembolism pathogenesis
(1 time)
|
Medicine
(1 time)
|
DVT (1 time)
EBM (1 time)
GCT (1 time)
|
2015 [Graduated compression therapy in prophylaxis of deep vein thrombosis in patients after stroke--scientific evidence review].
|
| 37 |
Venous thrombotic emboli
(1 time)
|
Neoplasms
(1 time)
|
AUC (1 time)
DLT (1 time)
PHH3 (1 time)
|
2011 Phase I study of GSK461364, a specific and competitive Polo-like kinase 1 inhibitor, in patients with advanced solid malignancies.
|
| 38 |
vessel tracking error
(1 time)
|
Biomedical Engineering
(1 time)
|
TRE (1 time)
|
2011 Tracking of vessels in intra-operative microscope video sequences for cortical displacement estimation.
|
| 39 |
virtual training environment
(1 time)
|
Behavioral Sciences
(1 time)
|
VR (1 time)
|
2007 Training cognitive skills in virtual reality: measuring performance.
|
| 40 |
visual-tactile caries examination
(1 time)
|
Dentistry
(1 time)
|
RE (1 time)
|
2013 Visual-tactile versus radiographic caries detection agreement in caries-active adults.
|
| 41 |
vitamin and trace element status
(1 time)
|
Gastroenterology
(1 time)
|
---
|
2020 Assessment and Interpretation of Vitamin and Trace Element Status in Sick Children. A Position Paper from the ESPGHAN Committee in Nutrition.
|
| 42 |
volume transmission-mediated encephalopathies
(1 time)
|
Neurology
(1 time)
|
CSF (1 time)
ISF (1 time)
ivNNA (1 time)
|
2012 Volume transmission-mediated encephalopathies: a possible new concept?
|
| 43 |
VT extract
(1 time)
|
Environmental Health
(1 time)
|
CT (1 time)
TT (1 time)
TTE and CTE (1 time)
|
2007 Wastewater toxicity of tannin- versus chromium-based leather tanneries in Marrakesh, Morocco.
|
| 44 |
VTE cannot be ruled out
(1 time)
|
Primary Health Care
(1 time)
|
CI (1 time)
|
2017 Incidence of venous thromboembolism in care homes: a prospective cohort study.
|
| 45 |
VTE date of the proband and until an event
(1 time)
|
Medicine
(1 time)
|
SIR (1 time)
|
2016 Familial Clustering of Venous Thromboembolism - A Danish Nationwide Cohort Study.
|
| 46 |
VTE was associated with a worse 1-year survival rate
(1 time)
|
Orthopedics
(1 time)
|
CI (1 time)
DVT (1 time)
OR (1 time)
|
2018 High Risk of Venous Thromboembolism After Surgery for Long Bone Metastases: A Retrospective Study of 682 Patients.
|
| 47 |
VTEpos
(1 time)
|
|
ANCA (1 time)
CI (1 time)
eGFR (1 time)
|
2019 Elevated Microparticle Tissue Factor Activity Differentiates Patients With Venous Thromboembolism in Anti-neutrophil Cytoplasmic Autoantibody Vasculitis.
|
A Search Service for Abbreviation / Long Form